ArticlePloS one2026
Assessment of post-pandemic NAAT-based diagnostic capacity among laboratories with COVID-19 testing resource investments in Indonesia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThroughout COVID-19 pandemic, many countries expanded their diagnostic infrastructure, including Indonesia. West Java, one of the most COVID-19-affected provinces in Indonesia, received many PCR machines during the pandemic but the molecular diagnostic landscape left post-pandemic needs to be assessed to build an improved pandemic preparedness in the area and enhance control of other diseases.
aimsTo evaluate the post-pandemic diagnostic capacity of district health laboratories (DHLs) in West Java, to determine factors associated with laboratories' performance capacities and to portray its DHLs' diagnostic profiles to explore the possibility of implementing an additional NAAT-based tuberculosis test in the province.
methodsThis was a cross-sectional laboratory survey, assessing 26 DHLs in West Java, Indonesia. Data were collected through direct visits, interviews based on questionnaire based on WHO Laboratory Assessment Tool, and focus group discussion. The questionnaire was then quantitatively scored and used to categorize capacity levels as strong (>=85%), good (70-84%), weak (50-69%), or very weak (<50%). Descriptive statistics were also used to highlight key gaps.
resultsOut of 26 DHLs, only 34.6% had strong NAAT-based diagnostic capacity, 34.6% had good capacity, while 30.8% were categorized as weak or lower. 80.8% of the DHLs scored weak or very weak in 'Laboratory Testing Performance' module, and only 11.5% of DHLs conducted PCR machine calibration in the past year. Only 46.2% maintained a functional BSL-2 laboratory, and the median of PCR-trained staff was 2 (IQR 1-4), with 15.4% DHLs no longer retaining any biomolecular staff.
conclusionThe sustainability of COVID-19 diagnostic investments post-pandemic is relatively poor across many districts in West Java. Commitment to sustain facilities and equipment, as well as to retain an adequate workforce, is warranted to strengthen pandemic preparedness in the area and to repurpose COVID-19 facilities for tuberculosis control purposes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.